{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T08:54:38Z","timestamp":1790758478205,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"vor","delay-in-days":45,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-43303-3","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T18:52:36Z","timestamp":1773773556000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Real-world use of rivaroxaban for primary thromboprophylaxis and cardiac thrombosis treatment in congenital and acquired heart disease: a prospective cohort study"],"prefix":"10.1038","volume":"16","author":[{"given":"Neil","family":"Derridj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Malekzadeh-Milani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Lasne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diala","family":"Khraiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugues","family":"Ndjoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Bajolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"issue":"12","key":"43303_CR1","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.amjmed.2011.06.009","volume":"124","author":"G Piazza","year":"2011","unstructured":"Piazza, G. et al. Anticoagulation-associated Adverse Drug Events. Am. J. Med. 124 (12), 1136\u20131142. https:\/\/doi.org\/10.1016\/j.amjmed.2011.06.009 (2011).","journal-title":"Am. J. Med."},{"key":"43303_CR2","unstructured":"Making Healthcare Safer IV: A Continuous Updating of Patient Safety Harms and Practices. Rockville (MD): Agency for Healthcare Research and Quality (US); (2023)."},{"key":"43303_CR3","unstructured":"Bajolle, F. et al. Home point-of-care international normalised ratio monitoring sustained by a non-selective educational program in children. Thromb Haemost."},{"issue":"9","key":"43303_CR4","doi-asserted-by":"publisher","first-page":"2914","DOI":"10.3390\/jcm14092914","volume":"14","author":"G Miceli","year":"2025","unstructured":"Miceli, G., Ciaccio, A. M. & Tuttolomondo, A. Challenges and Opportunities of Direct Oral Anticoagulant (DOAC) Therapy in Complex Clinical Scenarios: A Comprehensive Review and Practical Guide. J. Clin. Med. 14 (9), 2914. https:\/\/doi.org\/10.3390\/jcm14092914 (2025).","journal-title":"J. Clin. Med."},{"issue":"43","key":"43303_CR5","doi-asserted-by":"publisher","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","volume":"41","author":"E Freisinger","year":"2020","unstructured":"Freisinger, E. et al. Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. Eur. Heart J. 41 (43), 4168\u20134177 (2020).","journal-title":"Eur. Heart J."},{"issue":"10","key":"43303_CR6","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1016\/j.jtha.2023.07.011","volume":"21","author":"R Giossi","year":"2023","unstructured":"Giossi, R. et al. Efficacy and safety of direct oral anticoagulants in the pediatric population: a systematic review and a meta-analysis. J. Thromb. Haemost. 21 (10), 2784\u20132796 (2023).","journal-title":"J. Thromb. Haemost"},{"issue":"22","key":"43303_CR7","doi-asserted-by":"publisher","first-page":"e021765","DOI":"10.1161\/JAHA.120.021765","volume":"10","author":"BW McCrindle","year":"2021","unstructured":"McCrindle, B. W. et al. Thromboprophylaxis for Children Post-Fontan Procedure: Insights From the UNIVERSE Study. J. Am. Heart Assoc. 10 (22), e021765 (2021).","journal-title":"J. Am. Heart Assoc."},{"issue":"24","key":"43303_CR8","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1016\/j.jacc.2022.09.031","volume":"80","author":"MA Portman","year":"2022","unstructured":"Portman, M. A. et al. Edoxaban for Thromboembolism Prevention in Pediatric Patients With Cardiac Disease. J. Am. Coll. Cardiol. 80 (24), 2301\u20132310 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"43303_CR9","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ahj.2019.08.002","volume":"217","author":"RM Payne","year":"2019","unstructured":"Payne, R. M. et al. A multi-national trial of a direct oral anticoagulant in children with cardiac disease: Design and rationale of the Safety of ApiXaban On Pediatric Heart disease On the preventioN of Embolism (SAXOPHONE) study. Am. Heart J. 217, 52\u201363 (2019).","journal-title":"Am. Heart J."},{"issue":"7","key":"43303_CR10","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1111\/jth.14813","volume":"18","author":"G Young","year":"2020","unstructured":"Young, G. et al. Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose\u2010exposure\u2010response evaluation. J. Thromb. Haemost. 18 (7), 1672\u20131685. https:\/\/doi.org\/10.1111\/jth.14813 (2020).","journal-title":"J. Thromb. Haemost"},{"issue":"1","key":"43303_CR11","first-page":"73","volume":"36","author":"P Albaladejo","year":"2017","unstructured":"Albaladejo, P. et al. Management of direct oral anticoagulants in patients undergoing elective surgeries and invasive procedures: Updated guidelines from the French Working Group on Perioperative Hemostasis (GIHP) - September 2015. Anaesth. Crit. Care Pain Med. 36 (1), 73\u201376 (2017).","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"5","key":"43303_CR12","first-page":"101584","volume":"44","author":"D Douillet","year":"2025","unstructured":"Douillet, D. et al. Anticoagulant management in Emergency settings: 2024 guidelines from the French Society of Emergency Medicine (SFMU), the French Society of Anaesthesia and Intensive Care Medicine (SFAR), the French Society of Thrombosis and Haemostasis (SFTH) and the French Working Group on Perioperative Haemostasis (GIHP), endorsed by the French Neurovascular Society. Anaesth. Crit. Care Pain Med. 44 (5), 101584 (2025).","journal-title":"Anaesth. Crit. Care Pain Med."},{"issue":"11","key":"43303_CR13","first-page":"1719","volume":"20","author":"A Hern\u00e1ndez-Madrid","year":"2018","unstructured":"Hern\u00e1ndez-Madrid, A. et al. Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Eur. Eur. Pacing Arrhythm. Card Electrophysiol. J. Work Groups Card Pacing Arrhythm. Card Cell. Electrophysiol. Eur. Soc. Cardiol. 20 (11), 1719\u20131753 (2018).","journal-title":"Eur. Eur. Pacing Arrhythm. Card Electrophysiol. J. Work Groups Card Pacing Arrhythm. Card Cell. Electrophysiol. Eur. Soc. Cardiol."},{"issue":"6","key":"43303_CR14","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","volume":"21","author":"H Whitworth","year":"2023","unstructured":"Whitworth, H. et al. Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis. J. Thromb. Haemost JTH. 21 (6), 1666\u20131673 (2023).","journal-title":"J. Thromb. Haemost JTH"},{"issue":"6","key":"43303_CR15","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1016\/j.jtha.2023.03.005","volume":"21","author":"C VanderPluym","year":"2023","unstructured":"VanderPluym, C. et al. Real-world use of apixaban for the treatment and prevention of thrombosis in children with cardiac disease. J. Thromb. Haemost. 21 (6), 1601\u20131609 (2023).","journal-title":"J. Thromb. Haemost"},{"key":"43303_CR16","doi-asserted-by":"crossref","unstructured":"Rychik, J. et al. Evaluation and Management of the Child and Adult With Fontan Circulation: A Scientific Statement From the American Heart Association. Circulation ;140(6). (2019).","DOI":"10.1161\/CIR.0000000000000696"},{"issue":"1","key":"43303_CR17","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","volume":"7","author":"C Male","year":"2020","unstructured":"Male, C. et al. Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial. Lancet Haematol. 7 (1), e18\u2013e27 (2020).","journal-title":"Lancet Haematol."},{"issue":"3","key":"43303_CR18","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jpag.2019.02.119","volume":"32","author":"LJ Carlson","year":"2019","unstructured":"Carlson, L. J. & Shaw, N. D. Development of Ovulatory Menstrual Cycles in Adolescent Girls. J. Pediatr. Adolesc. Gynecol. 32 (3), 249\u2013253 (2019).","journal-title":"J. Pediatr. Adolesc. Gynecol."},{"issue":"1","key":"43303_CR19","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12905-024-02921-7","volume":"24","author":"EM Hall","year":"2024","unstructured":"Hall, E. M., Ravelo, A. E., Aronoff, S. C. & Del Vecchio, M. T. Systematic review and meta-analysis of the etiology of heavy menstrual bleeding in 2,770 adolescent females. BMC Womens Health. 24 (1), 136 (2024).","journal-title":"BMC Womens Health"},{"issue":"5","key":"43303_CR20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1111\/1471-0528.13273","volume":"122","author":"KA Matteson","year":"2015","unstructured":"Matteson, K. A., Scott, D. M., Raker, C. A. & Clark, M. A. The menstrual bleeding questionnaire: development and validation of a comprehensive patient-reported outcome instrument for heavy menstrual bleeding. BJOG Int. J. Obstet. Gynaecol. 122 (5), 681\u2013689 (2015).","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"12","key":"43303_CR21","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1111\/1471-0528.15388","volume":"125","author":"L Scheres","year":"2018","unstructured":"Scheres, L. et al. Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai- VTE study. BJOG Int. J. Obstet. Gynaecol. 125 (12), 1581\u20131589 (2018).","journal-title":"BJOG Int. J. Obstet. Gynaecol."},{"issue":"2","key":"43303_CR22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.medcli.2023.03.011","volume":"161","author":"JA Gir\u00f3n-Ortega","year":"2023","unstructured":"Gir\u00f3n-Ortega, J. A. & Gir\u00f3n-Gonz\u00e1lez, J. A. Anticoagulantes de acci\u00f3n directa en el s\u00edndrome antifosfol\u00edpido. Revisi\u00f3n sistem\u00e1tica. Med. Cl\u00ednica. 161 (2), 65\u201377 (2023).","journal-title":"Med. Cl\u00ednica"},{"issue":"6","key":"43303_CR23","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/j.ad.2017.01.015","volume":"108","author":"A Batalla","year":"2017","unstructured":"Batalla, A. et al. Cardiomyopathy in Patients With Hereditary Bullous Epidermolysis. Actas Dermosifiliogr. 108 (6), 544\u2013549 (2017).","journal-title":"Actas Dermosifiliogr"},{"key":"43303_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.thromres.2023.10.017","volume":"232","author":"F Bajolle","year":"2023","unstructured":"Bajolle, F. et al. Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study. Thromb. Res. 232, 93\u2013103 (2023).","journal-title":"Thromb. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43303-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43303-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:29:51Z","timestamp":1777588191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-43303-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["43303"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-43303-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was approved by the local ethics committee of our institution and is registered in the Assistance Publique-H\u00f4pitaux de Paris (AP-HP) General Registry of Treatments (\n                      N\u00b0025 0627151343\n                      ).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical appproval"}}],"article-number":"13923"}}